Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation

Journal of Stroke and Cerebrovascular Diseases

Volumn 27, Issue 4, 2018, Pages 839-844

  Al Kawaz, Mais ^a,b   Omran, Setareh S ^a,b   Parikh, Neal S ^a,b   Elkind, Mitchell S V ^c,d   Soliman, Elsayed Z ^e   Kamel, Hooman ^a,b  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Department of Neurology   (United States)

^d Mailman School of Public Health   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

arrhythmia; atrial fibrillation; atrial flutter; Stroke

Indexed keywords

ADMINISTRATIVE CLAIMS (HEALTH CARE); AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHA2DS2-VASC SCORE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM FLUTTER; HUMAN; HYPERTENSION; INCIDENCE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL ANALYSIS; CEREBROVASCULAR ACCIDENT; CHI SQUARE DISTRIBUTION; FACTUAL DATABASE; KAPLAN MEIER METHOD; MEDICARE; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; TIME FACTOR; UNITED STATES; VERY ELDERLY;

ADMINISTRATIVE CLAIMS, HEALTHCARE; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL FLUTTER; BRAIN ISCHEMIA; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MEDICARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; UNITED STATES;

EID: 85043477039     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2017.10.025     Document Type: Article

References (27)

1. Friberg, L., Rosenqvist, M., Lindgren, A., et al. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke 45 (2014), 2599–2605.
2. Leyden, J.M., Kleinig, T.J., Newbury, J., et al. Adelaide stroke incidence study: declining stroke rates but many preventable cardioembolic strokes. Stroke 44 (2013), 1226–1231.
3. Wolf, P.A., Abbott, R.D., Kannel, W.B., Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22 (1991), 983–988.
4. Lip, G.Y., Lim, H.S., Atrial fibrillation and stroke prevention. Lancet Neurol 6 (2007), 981–993.
5. Granada, J., Uribe, W., Chyou, P.H., et al. Incidence and predictors of atrial flutter in the general population. J Am Coll Cardiol 36 (2000), 2242–2246.
6. Lanzarotti, C.J., Olshansky, B., Thromboembolism in chronic atrial flutter: is the risk underestimated?. J Am Coll Cardiol 30 (1997), 1506–1511.
7. January, C.T., Wann, L.S., Alpert, J.S., et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130 (2014), 2071–2104.
8. Kirchhof, P., Benussi, S., Kotecha, D., et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Rev Esp Cardiol (Engl Ed), 70, 2017, 50.
9. Limited Data Set (LDS) files. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Files-for-Order/LimitedDataSets/, 2016. (Accessed 11 January 2017)
10. Yu, A.Y., Holodinsky, J.K., Zerna, C., et al. Use and utility of administrative health data for stroke research and surveillance. Stroke 47 (2016), 1946–1952.
11. Naccarelli, G.V., Varker, H., Lin, J., et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 104 (2009), 1534–1539.
12. Walkey, A.J., Hammill, B.G., Curtis, L.H., et al. Long-term outcomes following development of new-onset atrial fibrillation during sepsis. Chest 146 (2014), 1187–1195.
13. Jensen, P.N., Johnson, K., Floyd, J., et al. Identifying atrial fibrillation from electronic medical data: a systematic review. Pharmacoepidemiol Drug Saf 21 (2012), 141–147.
14. Tirschwell, D.L., Longstreth, W.T. Jr, Becker, K.J., et al. Shortening the NIH Stroke scale for use in the prehospital setting. Stroke 33 (2002), 2801–2806.
15. Writing Group Members, Mozaffarian, D., Benjamin, E.J., et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
16. Ntaios, G., Lip, G.Y., Makaritsis, K., et al. CHADS(2), CHA(2)S(2)DS(2)-VASc, and long-term stroke outcome in patients without atrial fibrillation. Neurology 80 (2013), 1009–1017.
17. Charlson, M.E., Pompei, P., Ales, K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
18. Singer, D.E., Chang, Y., Borowsky, L.H., et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc, 2, 2013, e000250.
19. Brembilla-Perrot, B., Girerd, N., Sellal, J.M., et al. Risk of atrial fibrillation after atrial flutter ablation: impact of AF history, gender, and antiarrhythmic drug medication. J Cardiovasc Electrophysiol 25 (2014), 813–820.
20. Biblo, L.A., Yuan, Z., Quan, K.J., et al. Risk of stroke in patients with atrial flutter. Am J Cardiol 87 (2001), 346–349 A349.
21. Wood, K.A., Eisenberg, S.J., Kalman, J.M., et al. Risk of thromboembolism in chronic atrial flutter. Am J Cardiol 79 (1997), 1043–1047.
22. Seidl, K., Hauer, B., Schwick, N.G., et al. Risk of thromboembolic events in patients with atrial flutter. Am J Cardiol 82 (1998), 580–583.
23. Rahman, F., Wang, N., Yin, X., et al. Atrial flutter: clinical risk factors and adverse outcomes in the Framingham Heart Study. Heart Rhythm 13 (2016), 233–240.
24. Halligan, S.C., Gersh, B.J., Brown, R.D. Jr, et al. The natural history of lone atrial flutter. Ann Intern Med 140 (2004), 265–268.
25. Vanassche, T., Lauw, M.N., Eikelboom, J.W., et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J, 36, 2015 281-287a.
26. Kamel, H., Okin, P.M., Elkind, M.S., et al. Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke 47 (2016), 895–900.
27. Goldberger, J.J., Arora, R., Green, D., et al. Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate. Circulation 132 (2015), 278–291.